Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Rothwell

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Economic Modeling Considerations for Rare DiseasesIsobel Pearson, Ben Rothwell, Andrew Olaye, et al.
Pharmacoeconomics - Open|December 17, 2020
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in EnglandBen Rothwell, Christopher Kiff, Caroline Ling, et al.
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Economic Modeling Considerations for Rare DiseasesIsobel Pearson, Ben Rothwell, Andrew Olaye, et al.
Pharmacoeconomics - Open|December 17, 2020
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in EnglandBen Rothwell, Christopher Kiff, Caroline Ling, et al.
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Pageof 1